![](https://ophthalmology360.com/wp-content/uploads/2024/03/AdobeStock_161997178-scaled.jpeg)
Machine learning and AI advances show promise with AMD mapping and tracking
By Janice English Long-awaited treatments for late-stage dry age-related macular degeneration (AMD; geographic atrophy) are a year underway in the United States, and the rest of the world is watching. The future of care appears promising, with a new era of sight-saving intervention in the pipeline. Enhanced diagnostic imaging and...
Read MoreContact Info
© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved